Evidence map›Paper›PMID 32728959›Full record

ArticleJournal of general internal medicine2020

Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative Study.

Ariel R Green, Cynthia M Boyd, Kathy S Gleason, Leslie Wright, Courtney R Kraus, Ruth Bedoy, Bianca Sanchez, Jonathan Norton, Orla C Sheehan, Jennifer L Wolff and 4 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03984396 nacompletednot on this map

Optimal Medication Management in Alzheimer's Disease and Dementia

TypeinterventionalSponsorKaiser PermanenteRan2019 to 2024Enrolled7,398ConditionsDementiaArmsEducational Materials - Patient & Clinician
NCT06335953 nacompletednot on this mapstarted 2024, after this paper: background citation

Demonstration of ALIGN: Aligning Medications With What Matters Most

TypeinterventionalSponsorJohns Hopkins UniversityRan2024 to 2025Enrolled474ConditionsPolypharmacy, Alzheimer's Disease and Related Dementias, Mild Cognitive ImpairmentArmsPharmacist-led deprescribing intervention
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Navigating Medication Risk in the ED: Communication Preferences of Older Adults Regarding Deprescribing.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026
    Article
  9. Review
  10. Multimorbidity in dementia: Current perspectives and future challenges.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  11. Article
  12. Engaging Patients in Discussions About Medication Deprescribing.Journal of general internal medicine · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Ariel R GreenDivision of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA. ariel@jhmi.edu.ORCID http://orcid.org/0000-0003-4127-4617
Cynthia M BoydDivision of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA.
Kathy S GleasonInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Leslie WrightInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Courtney R KrausInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Ruth BedoyInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Bianca SanchezUniversity of Colorado School of Medicine, Aurora, CO, USA.
Jonathan NortonDivision of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA.
Orla C SheehanDivision of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA.
Jennifer L WolffDepartment of Health Policy and Management, Roger C. Lipitz Center for Integrated Health Care, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Emily ReeveQuality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Matthew L MaciejewskiDurham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Medical Center, Durham, NC, USA.
Linda A WeffaldDepartment of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA.
Elizabeth A BaylissInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Kaiser Permanente · USJohns Hopkins University · USDuke University · USUniversity of Colorado Denver · USUniversity of South Australia · AU

Funding

U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BOYD, CYNTHIA MELINDA, STEINMAN, MICHAEL A. · 2019 to 2023
$9.9M
Optimal Medication Management in Alzheimer's Disease and DementiaR33AG057289 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BAYLISS, ELIZABETH A, BOYD, CYNTHIA MELINDA · 2019 to 2021
$2.2M
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring ProgramK24AG056578 · NIA · JOHNS HOPKINS UNIVERSITY · PI BOYD, CYNTHIA MELINDA · 2017 to 2021
$1.1M
Bladder Antimuscarinics in Dementia: A Model of Decisions About Potentially Inappropriate MedicinesK23AG054742 · NIA · JOHNS HOPKINS UNIVERSITY · PI GREEN, ARIEL · 2017 to 2020
$795k
Optimal Medication Management in Alzheimer's Disease and DementiaR21AG057289 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BAYLISS, ELIZABETH A, BOYD, CYNTHIA MELINDA · 2017 to 2018
$508k
NIA NIH HHS K23 AG054742NIA NIH HHS K23AG054742NIA NIH HHS K24 AG056578NIA NIH HHS R21 AG057289NIA NIH HHS R21AG057289NIA NIH HHS R24 AG064025NIA NIH HHS R33 AG057289
6 · The paper itself

Abstract

backgroundPatients with dementia and multiple chronic conditions (MCC) frequently experience polypharmacy, increasing their risk of adverse drug events.

objectivesTo elucidate patient, family, and physician perspectives on medication discontinuation and recommended language for deprescribing discussions in order to inform an intervention to increase awareness of deprescribing among individuals with dementia and MCC, family caregivers and primary care physicians. We also explored participant views on culturally competent approaches to deprescribing.

designQualitative approach based on semi-structured interviews with patients, caregivers, and physicians.

participantsPatients aged ≥ 65 years with claims-based diagnosis of dementia, ≥ 1 additional chronic condition, and ≥ 5 chronic medications were recruited from an integrated delivery system in Colorado and an academic medical center in Maryland. We included caregivers when present or if patients were unable to participate due to severe cognitive impairment. Physicians were recruited within the same systems and through snowball sampling, targeting areas with large African American and Hispanic populations. APPROACH: We used constant comparison to identify and compare themes between patients, caregivers, and physicians. KEY

resultsWe conducted interviews with 17 patients, 16 caregivers, and 16 physicians. All groups said it was important to earn trust before deprescribing, frame deprescribing as routine and positive, align deprescribing with goals of dementia care, and respect caregivers' expertise. As in other areas of medicine, racial, ethnic, and language concordance was important to patients and caregivers from minority cultural backgrounds. Participants favored direct-to-patient educational materials, support from pharmacists and other team members, and close follow-up during deprescribing. Patients and caregivers favored language that explained deprescribing in terms of altered physiology with aging. Physicians desired communication tips addressing specific clinical situations.

conclusionsCulturally sensitive communication within a trusted patient-physician relationship supplemented by pharmacists, and language tailored to specific clinical situations may support deprescribing in primary care for patients with dementia and MCC.

Indexed as

DementiaDeprescriptionsAgedCaregiversColoradoHumansMarylandPrimary Health Caredementiadeprescribingpatient-physician communication

Identifiers

PMID32728959
PMCPMC7728901
OpenAlexW3045735916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.